Example: Heart Attack

Clinical Trials on Escherichia coli Infections

Total 74 results

NCT03800147

Unknown status

Effects of Nutritional Fat on the Growth of Intestinal E. Coli

Conditions: Escherichia Coli Infections
NCT02853708

Completed

Epidemiology of ST131 in Besançon University Hospital

Conditions: Escherichia Coli Infections
NCT01644565

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Conditions: Escherichia Coli Infection
NCT00654108

Completed

Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects

Conditions: Escherichia Coli Infections
NCT01382095

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Conditions: Escherichia Coli Infection
NCT00362869

Terminated

Enteroaggregative E.Coli (EAEC)

Conditions: Escherichia Coli Infections
NCT02289794

Completed

Vaccine Against Escherichia Coli Infection

Conditions: E.Coli Infections
NCT03869593

Unknown status

Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria

Conditions: Escherichia Coli Infections; Staphylococcus Aureus
NCT04574596

Recruiting

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Conditions: E Coli Infection
NCT04117113

Recruiting

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)

Conditions: E. Coli Infection
NCT04087681

Active, not recruiting

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

Conditions: E.Coli Infections
NCT03596827

Completed

The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection

Conditions: Diarrhea
NCT00877708

Completed

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol

Conditions: E Coli Infections
NCT00298103

Completed

Antibiotic Resistant Community-Acquired E. Coli

Conditions: E Coli Infection
NCT00619580

Withdrawn

Ampicillin-sulbactam Resistant E.Coli at UPMC

Conditions: Positive E Coli Infections
NCT03576183

Completed

Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701

Conditions: Enterotoxigenic Escherichia Coli Infection; Diarrhea
NCT01324726

Completed

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Conditions: Escherichia Coli Infections; Klebsiella Pneumonia
NCT04634513

Not yet recruiting

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Conditions: Shigella Infection; Enterotoxigenic Escherichia Coli Infection
NCT00167986

Completed

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Conditions: Escherichia Coli Infections; Klebsiella Infections
NCT01406288

Completed

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4

Conditions: Hemolytic-uremic Syndrome; Escherichia Coli Infections
NCT03021434

Completed

Trial of Low-cost Microbiological Water Test Kits

Conditions: Diarrhea; E.Coli Infections
NCT02537847

Unknown status

Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli

Conditions: Infection Due to Escherichia Coli; Acute Pyelonephritis
NCT01114347

Completed

Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules

Conditions: Cross Infection; Bacteriuria
NCT00167999

Completed

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Conditions: Gram-Positive Bacterial Infections; Escherichia Coli Infections; Klebsiella Infections
NCT02541695

Completed

Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli

Conditions: Diarrhea; Gastroenteritis; Bacterial Infections; Escherichia Coli Infections